Agios Announces FDA Orphan Drug Designation Granted to Mitapivat
AGIO: Agios Pharmaceuticals, Inc.
2020-11-12 16:30:16
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
2020-11-12 16:30:16
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease